US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% WDC $415.29 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Clearmind Medicine Inc (CSE:CMND)

N/A UNCHANGED
Last Price Updated: 3:54 PM EDT, Mar 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc

< Previous 1 2 3 4 Next >
InvestorNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (OTC: CMNDF) Announces Featured Speaker for Psychedelics for Alcoholism series
Via Investor Brand Network
BioMedNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Enters Agreement with Aragen Life Sciences to Produce Innovative Drug Candidate
Via Investor Brand Network
PsychedelicNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0 ) Announces Strategic Board Appointments of Distinguished Addiction Experts
Via Investor Brand Network
InvestorNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Announces Provisional Patent Application Related to Drug-Assisted Psychotherapy Methods
Via Investor Brand Network
Topics Intellectual Property
InvestorNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Announces Strategic Board Appointment of Dr. Adi Zuloff-Shani
Via Investor Brand Network
PsychedelicNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) Engages Clinipace in Pursuit of FDA Approval for Therapeutics
Via Investor Brand Network
BioMedNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) to Host Live Event Highlighting New Potential Treatments for Alcohol Use Disorder, Binge Drinking
Via Investor Brand Network
InvestorNewsBreaks – Clearmind Medicine Inc. (CSE: CMND), The Hebrew University Partner to Focus on Development of Novel Psychedelic Drug
Via Investor Brand Network
< Previous 1 2 3 4 Next >